Treatment with an Anti-CK2 Synthetic Peptide Improves Clinical Response in COVID-19 Patients with Pneumonia. A Randomized and Controlled Clinical Trial
暂无分享，去创建一个
Y. Perera | G. Guillén | Ariadna Garcia | Ailyn C. Ramón | S. Perea | Jesús Pérez | D. Thompson | V. Muzio | I. Baladrón | C. Valenzuela | D. Chacón | G. Perera | P. Díaz | R. Reyes | M. M. Vazquez | L. R. Cruz | Mauro Rosales | George V. Pérez | A. Rittoles | R. Santana | Ariel González | L. Torres | Yania Valido | R. Rodriguez | Dania M. Vázquez-Bloomquist